NCT07557433

Brief Summary

The purpose of this study is to understand whether certain brain activity patterns that can appear at the beginning of anesthesia are related to how deep anesthesia remains during the operation. The main question of the study is: Do patients who show a pattern called burst suppression during the start of anesthesia experience deeper anesthesia during surgery? Patients who are scheduled for elective surgery under total intravenous anesthesia (TIVA) may take part in this study. During the operation, brain activity will be monitored using a sensor placed on the forehead (Bispectral Index, BIS monitor), which is already commonly used during anesthesia. Information such as BIS values and the doses of anesthesia medications given during the operation will be recorded. Participation in this study will not change the type of anesthesia or the routine care that patients receive during surgery. The study only involves recording and analyzing information collected during standard anesthesia monitoring.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
14mo left

Started Jun 2026

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 29, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

April 23, 2026

Last Update Submit

April 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • TBIS<40

    Total duration during the maintenance phase of anesthesia in which the BIS remains below 40, expressed as a proportion of total surgical time, compared between patients with and without burst suppression during induction

    During intraoperative period

Secondary Outcomes (8)

  • TBIS40-60

    During intraoperative period

  • TBIS>60

    During intraoperative period

  • TLOC

    During induction of anesthesia

  • BIS-LOC

    At the exact time of loss of consciousness (LOC)

  • TROC

    During emergence from anesthesia

  • +3 more secondary outcomes

Study Arms (2)

Burst Suppression Group

Patients who exhibited burst suppression during the anesthesia induction period, defined as a burst suppression ratio of ≥10% lasting for at least 1 minute

Non-Burst Suppression Group

Patients who did not exhibit burst suppression during the anesthesia induction period, defined as the absence of burst suppression with a burst suppression ratio ≥10% lasting for at least 1 minute

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A tertiary care center in Amasya, Turkey

You may qualify if:

  • Age between 18 and 75 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Scheduled for elective surgery
  • Surgery planned to be performed under total intravenous anesthesia (TIVA)

You may not qualify if:

  • Presence of neurological disease
  • Chronic use of sedative medications or antiepileptic drugs
  • Severe hepatic or renal dysfunction
  • Intraoperative administration of ketamine or dexmedetomidine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Amasya University Sabuncuoglu Serefeddin Training and Research Hospital

Amasya, Amasya, 05200, Turkey (Türkiye)

Location

Izmir Katip Celebi University Ataturk Training and Research Hospital

Izmir, İzmir, 35360, Turkey (Türkiye)

Location

Central Study Contacts

Bülent Meriç Çam, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist Physician

Study Record Dates

First Submitted

April 23, 2026

First Posted

April 29, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations